HPC
ASXC

HM Payson & Co’s Asensus Surgical, Inc. ASXC Stock Holding History

HM Payson & Co’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-134
Closed – – 1185
2021
Q3 		$0 Hold
134
– – ﹤0.01% 1140
2021
Q2 		$0 Hold
134
– – ﹤0.01% 1193
2021
Q1 		$0 Hold
134
– – ﹤0.01% 1204
2020
Q4 		$0 Hold
134
– – ﹤0.01% 1167
2020
Q3 		$0 Hold
134
– – ﹤0.01% 1077
2020
Q2 		$0 Hold
134
– – ﹤0.01% 948
2020
Q1 		$0 Hold
134
– – ﹤0.01% 991
2019
Q4 		$0 Hold
134
– – ﹤0.01% 981
2019
Q3 		$1K Hold
134
– – ﹤0.01% 932
2019
Q2 		$2K Buy
+134
New +$2.93K ﹤0.01% 923
2019
Q1 		– Sell
-134
Closed -$4K – 280
2018
Q4 		$4K Buy
+134
New +$6.09K 0.01% 108

Other funds holding ASXC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

HM Payson & Co's ASXC Position: Q4 2021 in Review

HM Payson & Co sold out of Asensus Surgical, Inc. (ASXC) in Q4 2021, closing a stake of 134 shares.

HM Payson & Co first reported a position in ASXC in Q4 2018 and held it in 11 quarters. The position peaked at $4K in Q4 2018. 114 funds tracked by Wall St. Rank hold ASXC as of Q4 2021.

  • HM Payson & Co reported no remaining Asensus Surgical, Inc. position as of Q4 2021 after selling out during the quarter.
  • HM Payson & Co sold 134 Asensus Surgical, Inc. shares in Q4 2021.
  • HM Payson & Co first reported a position in Asensus Surgical, Inc. in Q4 2018 and held it in 11 quarters.
  • HM Payson & Co's Asensus Surgical, Inc. position peaked at $4K in Q4 2018.
  • 114 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q4 2021.

Based on HM Payson & Co's 13F filing for Q4 2021, filed 15 Feb 2022.